Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,468,243
-
Total 13F shares
-
25,467,293
-
Share change
-
+2,262,107
-
Total reported value
-
$239,390,343
-
Put/Call ratio
-
0%
-
Price per share
-
$9.40
-
Number of holders
-
85
-
Value change
-
+$21,237,489
-
Number of buys
-
48
-
Number of sells
-
22
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q4 2016
As of 31 Dec 2016,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,467,293 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, FRANKLIN RESOURCES INC, Palo Alto Investors, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., Tekla Capital Management LLC, and JPMORGAN CHASE & CO.
This page lists
85
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.